KDM6B and osteoporosis: Knockdown of KDM6B significantly suppresses osteogenic differentiation to aggravate the osteoporosis, suggesting that KDM6B may present as therapeutic targets for promoting osteoblast differentiation and lead to clues for new treatment in osteoporosis.37